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Abstract
Little is known of the direct microbicidal activity of T cells in leprosy, so a lipopeptide consisting of the N-terminal 13 amino
acids lipopeptide (LipoK) of a 33-kD lipoprotein of Mycobacterium leprae, was synthesized. LipoK activated M. leprae infected
human dendritic cells (DCs) to induce the production of IL-12. These activated DCs stimulated autologous CD4
+ or CD8
+ T
cells towards type 1 immune response by inducing interferon-gamma secretion. T cell proliferation was also evident from
the CFSE labeling of target CD4
+ or CD8
+ T cells. The direct microbicidal activity of T cells in the control of M. leprae
multiplication is not well understood. The present study showed significant production of granulysin, granzyme B and
perforin from these activated CD4
+ and CD8
+ T cells when stimulated with LipoK activated, M. leprae infected DCs.
Assessment of the viability of M. leprae in DCs indicated LipoK mediated T cell-dependent killing of M. leprae. Remarkably,
granulysin as well as granzyme B could directly kill M. leprae in vitro. Our results provide evidence that LipoK could facilitate
M. leprae killing through the production of effector molecules granulysin and granzyme B in T cells.
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Introduction
The introduction of multidrug therapy in 1982 and the WHO
campaign for the ‘elimination of leprosy as a public health
problem’, have contributed greatly to the decrease in the
prevalence rate over the past three decades. But leprosy still
remains to be a public health problem in some countries, and the
number of new cases detected during the last three years, remain
steady [1]. The disease presents as a clinical spectrum that
correlates with the level of the immune response to the pathogen
[2]. Patients with lepromatous form of the disease have poor
cellular immunity, resulting in extensive intracellular proliferation
of Mycobacterium leprae bacilli in the skin and nerves. On the other
hand, patients with the tuberculoid form of the disease are
relatively resistant to the bacilli, so that few, if any, demonstrable
bacilli are seen in the lesions [2,3]. For patients with abundant
bacilli, whose lesions are characterized by type-2 cytokines, there is
a need to up-regulate the T-cell mediated type 1 immune
responses, by immunotherapeutic means to kill the bacilli.
We have previously identified a lipoprotein of M. leprae, a 33-kD
lipoprotein (ML0603) [4]. Truncated protein, having the N-
terminal 60 amino acids of 33-kD lipoprotein, had cytokine
inducing ability in human monocytes, in contrast to the C-
terminal 192 amino acids having no such ability [5]. In this study,
we synthesized the lipopeptide (LipoK) having the N-terminal 13
amino acids of the 33-kD M. leprae lipoprotein linked to tri-
palmitoylated portion of a lipid. Since GC mass spectrometry of
mycobacterial lipoproteins provided evidence for the presence of
three fatty acids (either palmitic, stearic or tuberculostearic acid),
we assumed that tri-palmitoylated peptide would represent the
natural lipoprotein of M. leprae [6,7]. Further, N-acyl transferase
(Lnt) activity was identified in mycobacteria, which transfers the
amide-linked acyl group to the N-terminal cysteine residue [6].
This presence of Lnt activity would indicate the presence of
triacylated lipoproteins in mycobacteria, although the exact lipid
structure of M. leprae lipoprotein is still to be determined.
Previously, it was observed that hexameric peptides with tri-
palmitoyl modification, corresponding to 19-kD and 33-kD
lipoproteins of M. leprae, partially activates cells through TLR2-
TLR1 heterodimers [8,9]. Since dendritic cells (DCs) are the most
potent antigen presenting cells capable of bacilli uptake, antigen
presentation and initiating acquired immune responses, DCs were
used as target antigen presenting cells, in the present study [10,11].
As expected, it was found that LipoK, delivered signals through
TLR2, and activated M. leprae infected DCs to produce abundant
IL-12, although, LipoK does not produce IL-12, in non-infected
DCs. Several mechanisms are known to be involved in the
clearance of intracellular bacteria, including interferon gamma
(IFN-c) release, apoptosis induction of the host cells and anti-
microbial activity of CD8
+ cytotoxic T lymphocytes (CTL) [12–
15]. CTL mediated killing of mycobacteria, was demonstrated in
tuberculosis by Thoma-Uszynski et al. They showed that CD8
+
CTL-mediated killing of M. tuberculosis was dependent on granule
exocytosis [16].
In the present study, we analyzed whether M. leprae infected
DCs, activated through LipoK could undergo functional changes
and subsequently induce type 1 T cell activation to kill the bacilli.
We observed that LipoK is a potent inducer of T cells equipped
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of M. leprae in host cells.
Materials and Methods
Ethics statement, cell culture and preparation of the
bacteria
Peripheral blood was obtained from healthy Japanese individ-
uals under informed consent. But no information of the donor
(exposure to bacilli) was provided. In Japan, BCG vaccination is
compulsory for children (0,4 years old). Monocyte-derived DCs
were differentiated from monocytes using GM-CSF and IL-4 as
described earlier [17,18]. Animal studies were carried out in strict
accordance with the recommendations from Japan’s Animal
Protection Law. The protocol was approved by the Experimental
Animal Committee, of the National Institute of Infectious
Diseases, Tokyo (Permit Number: 210001). M. leprae (Thai-53
strain) is passaged in athymic nu/nu mice (Clea Co, Tokyo) [19]. At
8 to 9 months post-infection, the footpads were processed to
recover M. leprae [20]. For all experiments, M. leprae was freshly
prepared. The multiplicity of infection (MOI) was determined
based on the assumption that DCs were equally susceptible to
infection with M. leprae [21], and immature DCs were infected
with M. leprae at MOI 50 in all experiments. Human cells without
the bacilli was cultured at 37uC, but when infected with the bacilli,
the cells were cultured at 35uC, which is the minimal temperature
at which the cells can survive in in-vitro experiments. LipoK having
the structure Palmitoyl-Cys((RS)-2,3-di(palmitoyloxy) -propyl)-
Leu-Pro-Asp-Trp-Leu-Ser-Gly-Phe-Leu-Thr-Gly-Gly-OH, was
synthesized by Bachem (Bubendorf, Switzerland). Using LAL
assay (QCL-1000, Lonza), endotoxin was undetectable in original
LipoK preparation (50 mg/ml). Therefore, any contaminating
LPS in the synthesized product could be ruled out. Monoclonal Ab
to TLR2 was kindly provided by Genentech, and mAb to
mannose receptor and DC-SIGN were obtained from BD
Biosciences. Parthenolide obtained from Santa-Cruz was used at
a concentration of 2 and 5 mM. CD40L (Pepro Tech) was used at
the concentration of 1 mg/ml, whenever needed.
Analysis of cell surface Ags on DCs and measurement of
IL-12 production
Immature DCs were stimulated with M. leprae and/or LipoK for
48 hours. The expression of cell surface antigens on DCs, were
analyzed using FACSCalibur flow cytometer (BD Biosciences).
Dead cells were eliminated from the analysis by staining with 7-
amino actinomycin D stain. For analysis of cell surface Ag, the
following mAb were used: FITC-conjugated mAb against HLA-
ABC (G46-2.6), HLA-DR (L243) and CD86 (FUN-1), purchased
from PharMingen, and CD83 (HB15a, Immunotech). The ability
of DCs to produce IL-12 on stimulation with either LipoK and/or
M. leprae, was assessed. DCs were stimulated with the Ags on day 4
after the start of culture from monocytes. After 24 hours, OptEIA
Human IL-12 (p70) ELISA Set (BD Biosciences) was used to
determine the concentration of IL-12 p70 in the culture
supernatant.
DC-T cell co-cultures
The ability of M. leprae-infected DCs to stimulate T cells was
assessed using an autologous DC-T cell co-culture. CD4
+ T cells
and CD8
+ T cells were purified using respective T cell enrichment
Set (BD IMag) from freshly thawed PBMCs. The purity of CD4
+/
CD8
+T cells was determined to be more than 95%. The purified
responder cells (1610
5 per well) were plated in 96-well round-
bottom tissue culture plates, and mitomycin C-treated DCs which
were pulsed with Ag, were added to give the indicated DC: CD4
+
or CD8
+ T cell ratio. Supernatants of DC-T cell co-cultures were
collected on day 4, and IFN-c production was measured by
ELISA, using Opt EIA Human IFN-c ELISA Set (BD
Biosciences). In other experiments, Ag-pulsed DCs were treated
with mAb to HLA-ABC (W6/32), HLA-DR (L243), CD86 (IT2.2)
or normal mouse IgG. For obtaining naı ¨ve T cells, anti-CD45RO
mAb (Dako) and anti-mouse IgG Ab Dynabeads M-450 (Invitro-
gen) were used to negatively select the cells. Since BCG is
compulsory for children in Japan, it is likely that naı ¨ve T cells
respond to M. leprae antigens, some of which are cross reactive to
M. bovis BCG.
Measurement of T cell proliferation by CFSE labeling
DCs stimulated with Ags were co-cultured with the CFSE
labeled total T cells. CFSE (Molecular Probes) was added at the
concentration of 1 mM and incubated at 37uC for 10 min and
stabilized according to the manufacturers’ protocol. A total of
1610
6 cells/well were seeded in a 24-well plate at a DC:T cell
ratio of 1:6. After 8 days co-culture, cells were co-stained with PE
conjugated anti-CD4 mAb and APC conjugated anti-CD8 mAb
(BD Biosciences). CFSE signal of gated T cells were analysed.
Confocal microscopy
Imaging of cells was performed using laser scanning microscope
LSM5-Exciter (Carl Zeiss). DCs grown on a 13-mm coverglass in a
24-well plate, were infected with M. leprae and/or stimulated with
LipoK for 48 hours. T cell from the same donor was purified using
the Dynal T cell isolation kit, and co-cultured with DCs for
additional 3 days, after washing out extracellular bacilli. Cells were
fixed in 2% paraformaldehyde, and the bacilli stained with 0.01%
auramine O as described [22]. Anti-M. leprae membrane (minus
LAM) polyclonal antibody was kindly provided by Dr. John S.
Spencer through the NIH/NIAID Leprosy Research Support
(N01 A1-25469). Fixed cells were blocked with normal human IgG
(10 mg/ml), and stained with the above polyclonal antibody (1 mg/
ml) for 30 min in PBS containing 0.1% saponin and 0.5% BSA,
and the secondary antibody used was Alexa Fluor 633-conjugated
goat anti-rabbit IgG (Molecular Probes), and images were
recorded on fluorescent confocal microscope using a 636 oil
objective, 488-nm and 633-nm lasers. Data was processed using
the LSM software ZEN 2007. All bacilli observed were not surface
attached as observed by section scanning (Z-stack Navigation).
Author Summary
We observed that LipoK (Mycobacterium leprae lipopeptide
with 13 amino acids) is capable of inducing a good
immune response in M. leprae infected human dendritic
cells (DCs). These activated DCs had up-regulated expres-
sion of costimulatory molecule CD86 as well as CD83 (well
known maturation marker) on their surface, and secreted
IL-12, which is an important cytokine involved in the host
defense against pathogens. Importantly, these mature DCs
were capable of further driving type 1 responses by
stimulating CD4
+ T cells and CD8
+ T cells for proliferation
and interferon-gamma production. Further, both subsets
of T cells were capable of producing cytotoxic granules:
granulysin and granzyme B. In vitro experiments proved
that these molecules are capable of killing M. leprae
directly. It is the first report of the type, which proves that
granulysin as well as granzyme B could partially kill M.
leprae. LipoK would facilitate in inducing the immune
responses in patients’ harboring M. leprae.
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granzyme B and granulysin
After 7 days co-culture of purified T cells with DC pulsed with
M. leprae and/or LipoK, intracellular detection of cytolytic effector
molecules was performed. Briefly, GolgiStop (BD Biosciences) was
added to the media for the last 12 hours of culture. Cells were first
surface stained, fixed, permeabilized, and finally stained with
FITC conjugated anti-perforin mAb or anti-granzyme B mAb or
isotype control IgG2a (BD Biosciences). For the determination of
intracellular levels of granulysin, the procedure was followed as for
the intracellular stain of perforin, except that the surface stain used
was FITC conjugated-CD4 and APC conjugated anti-CD8 mAb
(BD Biosciences), and subsequently PE conjugated granulysin
(eBioscience, GmbH, Germany) was used to determine the
percentage of granulysin producing cells.
Determination of M. leprae viability in DCs
Since M. leprae cannot be cultured in vitro, we measured the
viability of the bacilli, by the measurement of radioactive CO2
production from oxidation of palmitic acid as described previously
[23]. DCs were infected with M. leprae with or without LipoK, and
co-cultured with T cells in some cases. Six days later, cells were
harvested and washed 3 times in PBS, and centrifuged, so that M.
leprae that might have escaped from the DCs into the media could
be eliminated from our assay. Cell lysates were prepared as
follows: 0.1 N NaOH solution was added to the cells for few
minutes and then neutralized with the equal volumes of 0.1 N HCl
solution. Subsequently, equal volume of 2 times concentrated
Middlebrook 7H9 broth supplemented with ADC was added.
14C
labeled palmitic acid was added to the lysates of DCs and cultured
at 33uC. Seven days later, the amount of
14CO2 evolved and
trapped on the filter paper was measured using a Packard 1500
TRI-CARB liquid scintillation analyzer. In a likewise manner,
direct effect of M. leprae killing was observed by incubation of the
bacilli with 3 mg/ml of granulysin (R&D systems) or granzyme B
(Calbiochem) for a period of 3 days at 33uC, and then
14C labeled
palmitic acid was added to determine the viability as described
above.
Statistical analysis
The unpaired student’s t test was used to find the significance of
the two sets of data. Differences were considered as statistically
significant if p,0.05. All experiments were performed at least 3
times with different blood donors, unless otherwise stated, and the
reproducibility of the experiment was evaluated. In some cases,
ANOVA was used for probability calculation.
Results
LipoK activated human dendritic cells
We investigated the effect of LipoK stimulation on human
monocyte derived DCs. All DCs were CD1a positive and CD14
negative [21]. When LipoK was used as a stimulant for immature
DCs, maturation of DCs was observed as shown in Fig. 1. Up-
regulation in the expression of CD83 (maturation marker of DCs)
and CD86 (co-stimulatory molecule) was observed in LipoK
stimulated DCs, the level of which, was similar to that of M. leprae
infected DCs. M. leprae was used at the multiplicity of infection
(MOI): 50 in all the experiments. The expression of the CD83 and
CD86 molecules was more pronounced when LipoK was used to
stimulate M. leprae infected DCs. The expression of HLA-ABC and
HLA-DR molecules was not significantly different in LipoK
stimulated M. leprae infected DCs from non-infected DCs, after
48 hours. Although, at earlier time points (18 hours after
stimulation with antigen), a higher expression of HLA-ABC and
Figure 1. Expression of the surface markers on DCs after stimulation of M. leprae infected DCs with LipoK. The expression of cell surface
markers on DCs, was analyzed using FACSCalibur. Dead cells were eliminated from the analysis by staining with 7-amino actinomycin D (7-AAD) stain.
LipoK was used at a concentration of 0.3 mg/ml. The following mAb were used: FITC-conjugated mAb against HLA-ABC, HLA-DR, CD83 and CD86.
Black light lines, isotype-matched control IgG. Black solid lines show the fluorescence intensity of the respective surface markers of DCs. Numbers
indicate the mean fluorescence intensity with SD of the respective surface markers. Representative data of three separate experiments with different
donors is shown.
doi:10.1371/journal.pntd.0001401.g001
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compared to non-stimulated.
Alternatively, when the IL-12 p70 secreted by DCs was
measured, increasing dose of LipoK on M. leprae infected DCs
produced the cytokine, with maximal cytokine production at
LipoK concentration of 0.3 mg/ml (Fig. 2A). LipoK alone did not
produce statistically significant amounts of IL-12 at the concen-
tration of 0.3 mg/ml compared to the non-stimulated DCs.
Another TLR-2 agonist, peptidoglycan could produce IL-12 (data
not shown), probably due to the heterogeneous nature of the
peptidoglycan which contains long peptide linkages. LipoK
probably need other protein/peptide molecules to activate IL-12
production in DCs. Also, M. leprae infection alone did not produce
IL-12 in DCs. When CD40 ligand (CD40L) was used to stimulate
M. leprae infected DCs, IL-12 production was negligible.
As could be expected, TLR-2 antagonistic Ab completely
blocked IL-12 production, whereas mannose receptor Ab did not,
suggesting that IL-12 production from LipoK stimulated M. leprae
infected DCs was TLR-2 dependent (Fig. 2B). When DCs were
pre-treated with parthenolide, which is known to inhibit NF-kB
activity [24], it was found that both 2 mM and 5 mM could
significantly inhibit the production of IL-12 in a dose-dependent
manner (Fig. 2C), indicating that NF-kB is involved in the IL-12
production from these LipoK stimulated DCs.
LipoK pulsed human DCs activated human T cells ex vivo
To investigate the effect of LipoK on T cell responses, purified
CD4
+ and CD8
+ T cells from autologous donors were cultured
with activated DCs. IFN-c release was measured as correlates of T
cell activation. When the IFN-c levels were compared, DCs
activated with M. leprae and LipoK produced significantly higher
dose of IFN-c from CD4
+ T cells, when compared to that
produced by DCs stimulated with M. leprae or LipoK alone, or M.
leprae in presence of CD40L (Fig. 3A), at both high (T:DC=20:1)
and low (T:DC=40:1) dose of DCs. Note that M. leprae-infection
or LipoK-stimulation alone was not efficient in stimulating T cells.
Similarly, secretion of IFN-c was also observed from CD8
+ T cells
but at lower level compared to that from CD4
+ T cells. Again
there was significantly high production of IFN-c from CD8
+ T
cells co-cultured with LipoK stimulated M. leprae-infected DCs
compared to that from CD40L stimulated M. leprae-infected DCs
(Fig. 3A). Although the IL-12 p70 production differed in LipoK
stimulated M. leprae-infected DCs and CD40L stimulated DCs, no
IL-12 production was observed from these mitomycin treated DCs
which were co-cultured with T cells. In addition, as shown in
Fig. 3B, although normal murine IgG did not affect the T cell
stimulating activity of both CD4
+ and CD8
+ T cells, mAbs to
HLA-ABC and HLA-DR, inhibited CD8
+ T cells and CD4
+ T
cell activation of LipoK-stimulated M. leprae-infected DCs’
respectively. The results indicated that the activation of these T
cells were MHC Class II- and Class I-dependent in CD4
+ T cell
and CD8
+ T cells respectively. The inhibition was comparable to
that of inhibition of IFN-c production by mAb to co-stimulatory
molecule CD86.
Proliferation of these LipoK activated CD4
+ and CD8
+ T cells,
was confirmed by the CFSE labeling of T cells. The labeling
experiment was preferable because it could measure proliferation
of individual T cell subsets even in the presence of the other
subsets. M. leprae stimulation of DCs resulted in proliferation of
39.7% of total CD4
+ T cells, but stimulation with both LipoK
and M. leprae resulted in proliferation of 67.5% of total CD4
+ T
cells. LipoK stimulation alone did not induce any significant
proliferation of CD4
+ T cells (Fig. 3C). The profiles of flow
cytometric analyses showed that 25.3% of CD8
+ T cells
proliferated by stimulation with M. leprae alone, but higher
number of cells proliferated (38.9%) in presence of LipoK
stimulus.
Subsequently, we examined the response of naı ¨ve T cells to
LipoK activated DCs. When naı ¨ve CD4
+ T cells were cultured
with DCs activated with M. leprae and LipoK, significantly higher
dose of IFN-c was produced in comparison to those cultured with
DCs stimulated with M. leprae alone or LipoK alone. Production of
IFN-c was low from those activated with M. leprae and CD40L
(Fig. 3D). It was observed that the IFN-c production from naı ¨ve
CD8
+ T cells, co-cultured with DCs stimulated with M. leprae and
LipoK was meager.
When M. bovis BCG was used for infecting DCs, the MOI of the
bacilli had to be lowered to almost 1,10, because higher MOI
(50) would kill the DCs in in-vitro culture. BCG when infected at
MOI:1 produced 156 pg/ml of IFN-c from CD8 T cells, but
when LipoK was used to stimulate BCG infected DCs, the amount
of IFN-c increased to 380 pg/ml, indicating that LipoK could lead
to further T cell activation of BCG infected DCs. It is also likely
that LipoK stimulation could increase the production of perforin
and granulysin in M. tuberculosis infected host cells.
Figure 2. Production of IL-12 p70 from DCs. (A) Enhanced
induction of IL-12 p70 from DCs by stimulation with LipoK and M.
leprae. DCs were stimulated with the antigens on day 4 after the start of
culture from monocytes. After 24 hours, IL-12p70 concentration in the
culture supernatant was measured by the enzyme assay kit Opt EIA
Human ELISA Set. The antigens used for the stimulation were: M. leprae
and LipoK at different concentrations 0.1 mg/ml, 0.2 mg/ml, 0.3 mg/ml,
and 0.4 mg/ml, CD40L was used at 1 mg/ml. (B) IL-12 p70 production
from LipoK stimulated M. leprae infected DCs, is inhibited by
antagonistic antibodies to TLR-2, and not by control normal IgG. (C)
Effect of 2 mM and 5 mM of parthenolide (parthen.) on the IL-12
production was observed. Representative data of three separate
experiments with different donors is shown. The probability by ANOVA
was calculated to be 0.001 for (B) and 0.003 for (C).
doi:10.1371/journal.pntd.0001401.g002
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stimulate T cells was assessed using an autologous DC-CD4
+ or DC-CD8
+ T cell co-culture. IFN-c production in the supernatant was measured by
ELISA, after 4 days co-culture. (B) Effect of normal murine IgG or mAb to HLA-ABC/HLA-DR or CD86 on IFN-c production from T cells co-cultured with
M. leprae infected DCs simulated with LipoK. The production of IFN-c from Ab non-treated T cells, cultured with LipoK and M. leprae stimulated DCs, is
considered 100% and the actual value of IFN-c produced from CD4
+ T cells is 250 pg/ml and that from CD8
+ T cells is 47 pg/ml at T cell:DC ratio of
10:1. (C) Proliferation of CD4
+ and CD8
+ T cells as assessed by CFSE labeling of T cells. DCs were mixed with autologous CFSE labeled T cells at a T
cell:DC ratio of 10:1. Proliferating T cells were analysed by FACSCalibur on day 7 after co-culture. The percentage of proliferated cells is indicated. The
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production in CD4
+ and CD8
+ T cells
To determine whether cytotoxic effect could be induced in
highly activated T cells, we analysed the intracellular production
of perforin and granzyme B in DC co-culture system with
unseparated T cells. As seen in Fig. 4A, 15.8% of activated
CD8
high T cells produced perforin and 24.9% produced granzyme
B when stimulated with DCs activated with M. leprae and LipoK,
in comparison to those co-cultured with DCs activated with M.
leprae, showing 1.4% of perforin and 1.8% of granzyme B-
producing T cells. Thus, prominent enhancement of both perforin
and granzyme B producing CD8
+ T cells was observed. Recently,
since CD4
+ T cells are also known to possess direct cytotoxic
potential [25], we measured the percentage of CD4
+ T cells
producing perforin and granzyme B. When LipoK and M. leprae
stimulated DCs were co-cultured with T cells, 12.7% of CD4
high T
cells produced perforin and 14.6% of those cells produced
granzyme B, whereas in presence of M. leprae stimulated DCs,
6.6% produced perforin and 8.3% produced granzyme B (Fig. 4B).
These data indicated that in addition to CD8
+ T cells, CD4
+ T
cells also had the capacity to produce significant amounts of
perforin and granzyme B. Nevertheless, the percentage of CD8
+ T
cells producing these cytolytic proteins was 1.2,1.7 fold higher
than CD4
+ T cell. Then, we examined, whether CD8
+ T cells
alone without the direct contact with CD4
+ could have the same
capacity. When CD4
+ T cells were allowed to culture in inserts, so
that there was no direct contact between CD8
+ and CD4
+ T cells,
there was decreased production of both perforin (7.3% v/s 15.8%)
and granzyme B (9.5% v/s 24.9%) producing CD8
+ T cells
(Fig. 4A). So, a direct contact of CD4
+ and CD8
+ T cells was
necessary for sufficient production of cytolytic proteins. When we
examined whether exogenous IL-2 could substitute the action of
CD4
+ T cells, we found that addition of 50 U/ml of IL-2 (excess
amount) to CD8
+ T cells, could produce both perforin and
granzyme B equivalent to that of CD8
+ T cells co-cultured with
LipoK stimulated, M. leprae infected DCs in the presence of CD4
+
T cells. However such high levels of IL-2 cannot be produced from
host cells, in our experimental setting.
The intracellular level of another cytolytic protein, granulysin,
was then examined. Enhancement of granulysin producing CD8
+
T cells was observed when co-cultured with DCs activated with M.
leprae and LipoK. As seen in Fig. 4C, 18.9% of activated CD8
high
T cells and 28.4% of activated CD4
high T cells produced
granulysin when co-cultured with DCs activated with M. leprae
and LipoK, in comparison to those co-cultured with DCs activated
with M. leprae, (1.7% of CD8
high T cells and 0.6% of CD4
high T
cells).
Mycobacterium leprae components were observed at the
periphery of the infected DCs stimulated with LipoK, and
co-cultured with T cells
To examine the fate of M. leprae in activated DCs, the cells were
stained with anti-M. leprae membrane polyclonal antibody.
Confocal microscopy revealed rod shaped M. leprae as observed
by auramine-O stain, and membrane components seem to be
rather localized in the region where M. leprae are present (Fig. 5).
Strickingly, those DCs stimulated with LipoK for 48 hours and co-
cultured with T cells for additional 3 days showed membrane
staining at the periphery of the DCs (Fig. 5 arrowheads shown),
probably due to processing of the bacilli in activated DCs.
Killing of M. leprae in DCs, by the LipoK stimulation
We determined the viability of M. leprae in DCs after stimulation
with LipoK in the presence of autologous CD4
+ and CD8
+ T cells.
Since M. leprae is uncultivable in vitro, the viability of M. leprae in
DCs, after co-culture with the T cells for a week, was determined
by the radiorespirometric assay. The amount of radioactive CO2
evolved which reflects the rate of
14C-palmitic acid oxidized by M.
leprae, was measured by the scintillation counter. No significant
reduction in
14CO2 production was observed, from DCs, not co-
cultured with T cells, even in the presence of LipoK stimulation
(Fig. 6A). But, when the bacilli were recovered from DCs
stimulated with LipoK and co-cultured with T cells,
14CO2
production were significantly lower (p,0.001) than those recov-
ered from DCs not stimulated with LipoK or T cells. The result
indicates that approximately 50% reduction in the viability of M.
leprae was observed in LipoK activated DCs and co-cultured with
T cells compared to those obtained from DCs not stimulated with
LipoK (Fig. 6B), indicating that T cells were essential and LipoK
stimulation to DCs, was necessary to kill M. leprae in DCs. To
further determine whether the cytolytic granules namely, granu-
lysin and granzyme B could directly kill M. leprae, the bacilli was
incubated with human granulysin or granzyme B for a period of 3
days at 33uC. Statistically significant reduction of
14CO2 was
observed when the bacilli were incubated with granulysin as well
as granzyme B (Fig. 6C).
Discussion
In the present study we investigated the role of M. leprae-derived
synthetic lipopeptide (LipoK), which consists of N-terminal 13
amino acids of the 33-kD M. leprae lipoprotein (Accession
no. ML0603) linked to Palmitoyl-Cys((RS)-2,3-di(palmitoyloxy)-
propyl group in the induction of intracellular killing of M. leprae
through immuno-activation. Previously, we observed that the 33-
kD lipoprotein and the truncated form of the protein induced the
production of IL-12 in human peripheral blood monocytes [4,5].
Although human DCs are potent inducers of acquired immune
responses, when DCs were exposed to M. leprae, they are inefficient
in activating T cells [21,26]. It is generally recognized that,
stimulation of T cells by intracellular pathogens, such as
mycobacteria, is achieved by the coordinated processing of the
antigens in the phago-lysosome of APCs and the expression of the
antigenic determinants on APCs. Furthermore, CD40-CD40L
interaction on immature DCs, are known to contribute to cell
mediated responses in leprosy [27,28]. In fact, when M. leprae
infected DCs were stimulated with CD40L, up-regulation of
CD83 and CD86 molecules was observed (not shown). However,
we found that CD40L failed to induce the production of IL-12 p70
in M. leprae infected DCs. In contrast to CD40L stimulation,
LipoK stimulation on M. leprae infected DCs induced significant
production of IL-12. Further, the expression of CD40 on DCs was
not enhanced by stimulating M. leprae infected DCs with LipoK. It
was evident that IL-12 inducing ability of these matured DCs was
mediated by TLR2, and not by other receptors such as mannose
receptor or DC-SIGN, as observed in DCs exposed to M.
tuberculosis or M. bovis BCG [29,30,31]. The TLR2 antagonistic
lowest histogram shows unstimulated T cells. (D) IFN-c production from DC-naı ¨ve CD4
+ T cell co-culture. IFN-c production was measured after 4 days
co-culture with stimulated DCs. Representative data of four separate experiments with different donors is shown. Assays were performed in triplicate
and the results are expressed as the mean +SD.
doi:10.1371/journal.pntd.0001401.g003
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+ T cells as well as CD4
+ T cells. (A) Enhanced production of perforin
and granzyme B from CD8
+ T cells cultured with LipoK stimulated M. leprae infected DCs. Intracellular staining of perforin and granzyme B was
performed as follows: Cells were first stained with PE conjugated anti-CD4 or APC conjugated anti-CD8 mAb. Then, the cells were fixed in 2%
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DCs, as well as the T cell activating function of DCs (not shown),
probably through blocking of the classical NF-kB pathway.
Indeed, parthenolide, one of the major sesquiterpene lactones,
known to inhibit NF-kB activity [24], inhibited the IL-12
production from DCs stimulated with M. leprae and LipoK. Also,
IL-12 was efficiently produced when M. leprae was viable and not
dead. Thus, although the exact mechanisms remain to be
elucidated, some cell surface molecules and secreted components
of M. leprae are responsible for the production of IL-12, which
further modulates type 1 T cell responses [32,33].
A number of mechanisms are known to be involved in the
clearance of intracellular bacteria, such as IFN-c release, apoptosis
induction of the macrophages and anti-microbial activity of CTL
[12,15]. Production of IFN-c could boost the ability to kill
pathogens in host cells. In fact, it was found that LipoK activated
M. leprae infected DCs, highly stimulated both memory CD4
+ and
CD8
+ T cells, as well as naı ¨ve CD4
+ to produce IFN-c, and further
assisted in the proliferation of both T cell subsets (Fig. 3).
Inhibition of MHC class I and class II molecules on DCs,
indicated that the activation of these T cells were MHC class II-
and class I-dependent in CD4
+ T cell and CD8
+ T cells
respectively. Further, proteolytic processing of M. leprae antigens
was probably enhanced by LipoK treatment of DCs, since
incubation with anti-M. leprae membrane Ab showed positive
staining at the periphery of DCs, when co-cultured with T cells
(Fig. 5). In addition, preliminary results showed that expression of
MHC class I and II molecules on LipoK activated DCs, were
elevated in those co-cultured with T cells. Thus, LipoK could
probably assist in the processing and presentation of M. leprae
antigens, and thereby, highly activate T cells.
The other important parameter, for the clearance of mycobac-
teria from the host cell, is their potential to activate antimicrobial
effector mechanisms in human T cells. DCs have been shown to
be involved in CTL induction following uptake of antigenic
particles [25,34,35,36]. CD8
+ T cells co-cultured with LipoK
formaldehyde, permeabilized in 0.1% saponin, and stained with FITC conjugated anti-perforin mAb or anti-granzyme B mAb or isotype control IgG2a.
Figure shows the dot plot of the gated CD8
+ T cells. The right hand quadrant shows CD8
high T cells (activated CD8
+ T cells) and the number indicates
the percentage of perforin or granzyme B positive T cells among gated CD8
high T cells. *To determine whether direct interaction between CD4
+ and
CD8
+ T cells for perforin and granzyme B production from CD8
+ T cells, is needed, CD4
+ T cells were cultured in inserts in a 24-well plate, and were
not allowed to interact directly with CD8
+ T cells. As a control experiment, exogenous IL-2 (in the left hand dot plot) at a concentration of 50 U/ml
was added to CD8
+ T cells. (B) Enhanced expression of perforin and granzyme B from CD4
+ T cells. The right hand quadrant shows CD4
high T cells, and
the number indicates percentage of CD4
high T cells producing perforin and granzyme B. (C) Enhanced expression of granulysin from CD8
+ and CD4
+ T
cells, co-cultured with LipoK and M. leprae stimulated DCs. The protocol was followed as per the staining of perforin, except that the surface stain
used was FITC conjugated-CD4 and APC conjugated anti-CD8 mAb, and subsequently PE conjugated granulysin was used. Figure shows the dot plot
of the gated CD8
+ and CD4
+ T cells. The right hand quadrant shows CD8
high or CD4
high T cells (activated T cells) and the number indicates the
percentage of granulysin positive T cells among gated CD8
high and CD4
high T cells. Representative data of three separate experiments with different
donors is shown.
doi:10.1371/journal.pntd.0001401.g004
Figure 5. Localization of the membrane components of M.
leprae at the periphery of the DCs. DCs were infected with either M.
leprae alone or further stimulated with LipoK for 2 days and in some
cases co-cultured with T cells. After 3 days co-culture with T cells, cover
glass with attached DCs were fixed and observed under confocal
microscopy-LSM5 Exciter. M. leprae was stained with Auramine O
(shown in green) and M. leprae membrane components were stained
with polyclonal rabbit antibody raised against the membrane fraction of
M. leprae (depicted in red fluorescence). Alexa Fluor 633 conjugated
anti-rabbit antibody (Molecular Probes) was used as the secondary
antibody. Arrowheads indicate the positively stained region. Experi-
ments were performed twice with different donors.
doi:10.1371/journal.pntd.0001401.g005
Figure 6. Reduction in the viability of M. leprae in DCs after co-
culture with T cells and LipoK stimulation. (A) DCs were infected
with M. leprae and stimulated with LipoK, 2 days later, cells were
collected and the viability of M. leprae in DCs was measured by the
radiorespirometric assay (metabolic CO2 release) as described in
Materials and Methods. In brief,
14C labeled palmitic acid was added
to the lysates of DCs and cultured at 33uC. After 7 days of culture, the
amount of
14CO2 evolved was measured using a Packard 1500 TRI-CARB
liquid scintillation analyzer. (B) DCs were infected with M. leprae as in A,
and co-cultured with T cells. Six days after the co-culture, DCs were
lysed, and the viability of M. leprae was determined by the
radiorespirometric assay. (C) M. leprae at a concentration of 1610
7/
well/200 ml in Middlebrook 7H9 media was incubated with granulysin
or granzyme B for a period of 3 days at 33uC, and the viability
determined as described in A. Unpaired Student’s t test was used to
find the statistical significance of the two sets of data. Representative
data of three separate experiments is shown.
doi:10.1371/journal.pntd.0001401.g006
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+ T cells’ help
produced increased amount of cytolytic effector molecules:
perforin and granzyme B. Adequate production of these cytolytic
proteins from CD8
+ T cells required direct contact with CD4
+ T
cells. Recently, there are studies that certain types of CD4
+ T cells
possess direct cytotoxic potential [25,37,38]. We observed a
portion of CD4
high T cells (activated T cells), have the capacity to
produce cytotoxic granules. Bastian et al. demonstrated that native
M. tuberculosis heterogenous lipopeptides are potent immunogens
for primary human T cells, and those T cells were CD4
+ and
MHC class II restricted, challenging the current concepts that
cytotoxic T cells were restricted to CD8
+ T cell subset [25].
Another lytic molecule, present in cytotoxic granules of T cells, is
granulysin, which is reported to have direct anti-bacterial activity.
Reports have shown the ability of T cells to secrete granulysin at
the site of M. leprae infection, which provides evidence that anti-
microbial activity of granule containing T cells is a mechanism of
host defense in leprosy [39,40]. We observed that LipoK
stimulated, M. leprae infected DCs, highly enhanced the production
of granulysin from CD8
+ T cells. Unexpectedly, we observed that
the percentage of CD4
+ T cells producing granulysin was higher
than CD8
+ T cells. But, this fact was in lines with the earlier data,
which showed co-localization of granulysin and CD4
+ T cells in
tuberculoid leprosy lesions [39,40]. Thus, granulysin release by
LipoK-mediated activation process, may lead to a direct anti-
microbial effector pathway of host defense. These data demon-
strated that both CD4
+ T cells and CD8
+ T cells, contribute to the
induction of intracellular killing of M. leprae. These speculations
were further supported by the fact that 50% of the phagocytosed
bacilli were killed when infected DCs stimulated with LipoK, were
co-cultured with T cells. This is the first observation of killing of M.
leprae in an ex vivo system using human DCs and T cells. To further
provide evidence of the effector mechanism at work during M.
leprae killing by CTL, the direct effect of granulysin on M. leprae
killing in vitro was analyzed. Results indicated that about 40% of M.
leprae was killed by granulysin. Granulysin could probably lyse M.
leprae by binding to the lipidic cell wall, through the same
mechanism by which M. tuberculosis is destroyed by granulysin.
Since, perforin is an essential molecule in the killing of intracellular
M. tuberculosis [16], similar operation may be involved in
intracellular M. leprae killing since perforin was effectively
produced by T cells in our CTL culture system. On the other
hand, direct killing of mycobacteria by granzymes is not known.
But the viability of M. leprae was significantly lowered by granzyme
B. Since granzyme B is one of the serine proteases that can target
cytosolic and nuclear substrates to induce host cell death through
mitochondrial perturbation, it may be involved in destroying the
cell wall architecture of M. leprae by still unknown mechanism
[41,42]. The contribution of the cytotoxic granules to killing of
bacteria remains to be of interest for further investigation.
Together, the results indicate that LipoK could contribute to
protective host response against leprosy and eventually kill the
bacteria, through the production of perforin, granulysin and
granzyme B in T cells.
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